NAFLD patients: cost effectiveness of different strategies for detecting cirrhosis

Several strategies are available for detecting cirrhosis in patients with NAFLD, but their cost effectiveness is not clear. E. Vilar-Gomez et al. (Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA) developed a decision model to...
PUBLISHED IN: Clin Gastroenterol Hepatol 2020

Commentary

Several strategies are available for detecting cirrhosis in patients with NAFLD, but their cost effectiveness is not clear. E. Vilar-Gomez et al. (Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA) developed a decision model to quantify the accuracy and costs of 9 single or combination strategies, including FIB-4, vibration-controlled transient elastography, and magnetic resonance elastography, and liver biopsy, for the detection of cirrhosis in patients with NAFLD. This cost-effectiveness analysis is based on the US health care system.

These authors found that results from FIB-4, followed by either VCTE, MRE, or liver biopsy, detect cirrhosis in patients with NAFLD with a high level of accuracy and low cost.

Share the article
Avatar photo

Dr. G. Bozet, MD

Articles: 174

Leave a Reply

Your email address will not be published. Required fields are marked *

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES